Literature DB >> 17967799

A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.

Masahiro Hagiwara1, Kunihiro Yamagata, Tsuneaki Matsunaga, Yoh Arakawa, Joichi Usui, Yoshio Shimizu, Kumi Aita, Michio Nagata, Akio Koyama, Bo Zhang, Akira Mastunaga, Keigiro Saku, Takao Saito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17967799     DOI： 10.1093/ndt/gfm735

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

1.  Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.

Authors:  Akira Matsunaga; Masayuki Furuyama; Taeko Hashimoto; Kentaro Toyoda; Daisuke Ogino; Kiyoshi Hayasaka
Journal:  Clin Exp Nephrol       Date:  2009-07-15       Impact factor: 2.801

Review 2.  Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.

Authors:  Akira Matsunaga; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2014-02-26       Impact factor: 2.801

Review 3.  A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.

Authors:  Efstratios Stratikos; Angeliki Chroni
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

4.  Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.

Authors:  Maria Katsarou; Efstratios Stratikos; Angeliki Chroni
Journal:  J Lipid Res       Date:  2018-10-11       Impact factor: 5.922

5.  Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction.

Authors:  Young Chul Youn; Yong Kwan Lim; Su-Hyun Han; Vo Van Giau; Mi-Kyung Lee; Kwang-Yeol Park; SangYun Kim; Eva Bagyinszky; Seong Soo A An; Hye Ryoun Kim
Journal:  Clin Interv Aging       Date:  2017-07-11       Impact factor: 4.458

Review 6.  Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.

Authors:  Eduardo Cambruzzi; Karla Lais Pêgas
Journal:  J Bras Nefrol       Date:  2018-11-08

7.  A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.

Authors:  Runxiu Wang; Chengbo Zhao; Wen Chen; Zhiping Liu; Fuhua Xie
Journal:  J Med Case Rep       Date:  2022-02-23

8.  The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.

Authors:  Hongyan Wu; Yuan Yang; Zhangxue Hu
Journal:  J Atheroscler Thromb       Date:  2018-02-02       Impact factor: 4.928
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.